Target Name: SHC2
NCBI ID: G25759
Review Report on SHC2 Target / Biomarker Content of Review Report on SHC2 Target / Biomarker
SHC2
Other Name(s): SHCB | protein Sck | src homology 2 domain-containing-transforming protein C2 | SHC (Src homology 2 domain containing) transforming protein 2 | SHC2 variant 1 | ShcB | Neuronal Shc adaptor homolog | SHC-transforming protein B | SH2 domain protein C2 | SHC2_HUMAN | SHC adaptor protein 2 | neuronal Shc adaptor homolog | Protein Sck | SHC adaptor protein 2, transcript variant 1 | SCK | SLI | Src homology 2 domain-containing-transforming protein C2 | SHC-transforming protein 2 | SHC-transforming protein 2 (isoform 1)

SHC2: A Potential Drug Target and Biomarker

SHC2 ( Short for Sodium Chloride) is a molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer. SHC2 is a transmembrane protein that is expressed in many different tissues and cells in the body. It is involved in a variety of physiological processes, including cell signaling, membrane structure, and renal function.

One of the key functions of SHC2 is its role in the regulation of sodium levels in the body. Sodium is essential for many different functions in the body, including muscle and nerve function, nerve signaling, and the proper functioning of the brain. However, too much sodium can be harmful, and SHC2 helps to regulate the amount of sodium that enters and leaves cells.

In addition to its role in sodium regulation, SHC2 is also involved in a number of other cellular processes that are important for normal cell function. For example, SHC2 has been shown to be involved in the regulation of cell adhesion, which is the process by which cells stick together to form tissues and organs. SHC2 also plays a role in the regulation of cell proliferation, which is the process by which cells grow and divide.

One of the most promising aspects of SHC2 is its potential as a drug target. By targeting SHC2 with small molecules or other compounds, researchers hope to be able to inhibit its functions and disrupt its role in the development of various diseases. This could lead to a wide range of potential therapeutic approaches, including treatments for cancer, neurodegenerative diseases, and other conditions.

In addition to its potential as a drug target, SHC2 has also been identified as a potential biomarker for a number of diseases. By analyzing the levels of SHC2 in body tissues or fluids, researchers may be able to develop diagnostic tests for diseases that are characterized by abnormal levels of this protein. This could be a valuable tool for the early detection and treatment of disease.

Overall, SHC2 is a fascinating molecule that has the potential to be a drug target and biomarker for a wide range of diseases. Further research is needed to fully understand its functions and potential therapeutic applications.

Protein Name: SHC Adaptor Protein 2

Functions: Signaling adapter that couples activated growth factor receptors to signaling pathway in neurons. Involved in the signal transduction pathways of neurotrophin-activated Trk receptors in cortical neurons (By similarity)

The "SHC2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SHC2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

SHC3 | SHC4 | SHCBP1 | SHCBP1L | SHD | SHE | SHF | SHFL | SHH | SHISA2 | SHISA3 | SHISA4 | SHISA5 | SHISA6 | SHISA7 | SHISA8 | SHISA9 | SHISAL1 | SHISAL2A | SHISAL2B | SHKBP1 | SHLD1 | SHLD2 | SHLD2P1 | SHLD2P3 | SHLD3 | SHMT1 | SHMT2 | SHOC1 | SHOC2 | Short transient receptor potential channel (TrpC) | SHOX | SHOX2 | SHPK | SHPRH | SHQ1 | SHROOM1 | SHROOM2 | SHROOM3 | SHROOM4 | SHTN1 | SI | SIAE | SIAH1 | SIAH2 | SIAH3 | Sialidase | Sialyltransferase | SIDT1 | SIDT2 | SIGIRR | SIGLEC1 | SIGLEC10 | SIGLEC11 | SIGLEC12 | SIGLEC14 | SIGLEC15 | SIGLEC16 | SIGLEC17P | SIGLEC5 | SIGLEC6 | SIGLEC7 | SIGLEC8 | SIGLEC9 | SIGLECL1 | sigma Receptor | SIGMAR1 | Signal peptidase complex | Signal recognition particle | Signal recognition particle receptor | Signal Transducers and Activators of Transcription (STAT) | SIK1 | SIK2 | SIK3 | SIKE1 | SIL1 | SILC1 | SIM1 | SIM2 | SIMC1 | SIN3 complex | SIN3A | SIN3B | SINHCAF | SIPA1 | SIPA1L1 | SIPA1L1-AS1 | SIPA1L2 | SIPA1L3 | SIRPA | SIRPAP1 | SIRPB1 | SIRPB2 | SIRPB3P | SIRPD | SIRPG | SIRPG-AS1 | SIRT1 | SIRT2 | SIRT3